CurrentBlue Cross Blue Shield - TennesseePolicy N/A

Urine Culture Testing for Bacteria

Customize your policy alerts

Sign up for all blue cross blue shield - tennessee policy alerts

Know when blue cross blue shield - tennessee releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Criteria for coverage of urine culture testing (including isolate identification and antibiotic susceptibilities) for diagnosing and managing urinary tract infections and bacteriuria for BlueCross BlueShield of Tennessee members.

Policy Summary

PayerBlue Cross Blue Shield - Tennessee

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionDocument pregnancy status, planned mucosa‑breaching urologic interventions, or signs/symptoms of UTI to support coverage.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

6explicit coverage statements

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentBlue Cross Blue Shield - TennesseePolicy N/A

Urine Culture Testing for Bacteria

Customize your policy alerts

Sign up for all blue cross blue shield - tennessee policy alerts

Know when blue cross blue shield - tennessee releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerBlue Cross Blue Shield - Tennessee

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionDocument pregnancy status, planned mucosa‑breaching urologic interventions, or signs/symptoms of UTI to support coverage.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

6explicit coverage statements

Coverage Criteria for Urine Culture Testing

Medically necessary/Meets coverage criteria

Covered when ANY of the following are met

Covered indications: 1) Pregnant individuals; 2) Asymptomatic individuals undergoing urological interventions which breach the mucosa, when testing is prior to the procedure; 3) Individuals exhibiting at least one sign or symptom of a possible UTI or bacteriuria (see Note 1 for examples); 4) Assessment of pyelonephritis.any of the listed conditions

Signs/symptoms listed in Note 1 include fever, urgency, feeling the need to urinate despite an empty bladder, increased frequency, dysuria, suprapubic tenderness, pyuria, hematuria, cloudy urine, flank pain, nausea/vomiting, chills, night sweats, pelvic pressure, change in urine smell, abnormal urinalysis findings.

Not medically necessary / Does not meet coverage criteria

Not covered in the absence of the above indications

Not covered situations: 1) All other instances of asymptomatic UTI or asymptomatic bacteriuria not described in the covered indications; 2) Follow-up urine culture testing for an uncomplicated UTI in individuals showing evidence of clinical resolution; 3) Initial screening for asymptomatic prostatitis; 4) Urine culture as part of assessment or prognosis of prostate biopsy.none of the covered indications present

These situations DO NOT MEET COVERAGE CRITERIA as stated in the policy.

Initial screening for asymptomatic prostatitis and performing urine culture as part of the assessment or prognosis of a prostate biopsy are explicitly excluded from coverage. The policy states that these indications "DOES NOT MEET COVERAGE CRITERIA" due to insufficient published evidence supporting benefit for diagnosis or treatment in these contexts.

Urine culture testing for asymptomatic bacteriuria is not covered except in the specifically listed situations (see covered indications). The policy lists covered indications such as pregnancy and asymptomatic individuals undergoing urological interventions that breach the mucosa (pre-procedure); outside those and other covered indications, urine culture testing "DOES NOT MEET COVERAGE CRITERIA."

Follow-up urine culture testing after clinical resolution of an uncomplicated UTI is also not covered. The policy specifically states that for individuals who show evidence of clinical resolution, "follow-up urine culture testing for an uncomplicated UTI DOES NOT MEET COVERAGE CRITERIA."

Applicable Procedure Codes

Applicable CPT CodesCPT

87077	Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate
87086	Culture, bacterial; quantitative colony count, urine
87088	Culture, bacterial; with isolation and presumptive identification of each isolate, urine
87140	Culture, typing; immunofluorescent method, each antiserum
87147	Culture, typing; immunologic method, other than immunofluorescence (eg, agglutination grouping), per antiserum
87149	Culture, typing; identification by nucleic acid (DNA or RNA) probe, direct probe technique, per culture or isolate, each organism probed
87181	Susceptibility studies, antimicrobial agent; agar dilution method, per agent (eg, antibiotic gradient strip)
87186	Susceptibility studies, antimicrobial agent; microdilution or agar dilution (minimum inhibitory concentration [MIC] or breakpoint), each multi-antimicrobial, per plate

Provider Actions, Documentation & Billing Notes

Prior Authorization

Procedure codes referenced (no prior authorization stated)

Procedure codes relevant to urine culture and susceptibility testing are listed for billing reference; the policy does not state an explicit prior authorization requirement.

Step Therapy

No step therapy requirements

No step therapy requirements are described in this policy.

Background and Clinical Context

Bacteriuria may be symptomatic or asymptomatic and is commonly accompanied by pyuria. Urine culture testing identifies the presence of bacteria and, when performed, can include isolate identification and antibiotic susceptibility testing to guide management. The policy emphasizes that the utility of urine culture differs by population: it meets coverage criteria for pregnant individuals, for asymptomatic patients prior to urologic procedures that breach the mucosa, for individuals with at least one sign or symptom of possible UTI or bacteriuria (see Note 1), and for assessment of pyelonephritis; conversely, many other asymptomatic situations and routine post-resolution follow-up cultures are not considered medically necessary.

Definitions

inv-11: Bacteriuria — The presence of bacteria in the urine.

DefinitionThe presence of bacteria in the urine.

Typical associated findingOften accompanied by pyuria (pus in the urine) in infected persons.

Clinical contextMay be present in symptomatic or asymptomatic urinary tract infections.

Diagnostic utilityUrine culture can determine presence of bacteria and characterize the bacterial infection.

inv-12: UTI (urinary tract infection) — Infection of the urinary system which can be symptomatic or asymptomatic and includes cystitis, pyelonephritis, urosepsis, urethritis, an...

DefinitionInfection of the urinary system that can be symptomatic or asymptomatic and includes cystitis, pyelonephritis, urosepsis, urethritis, and male-specific infections such as bacterial prostatitis and epididymitis.